News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
416,152 Results
Type
Article (28147)
Company Profile (115)
Press Release (387886)
Multimedia
Podcasts (66)
Webinars (13)
Section
Business (103499)
Career Advice (553)
Deals (18246)
Drug Delivery (91)
Drug Development (39105)
Employer Resources (82)
FDA (10931)
Job Trends (10136)
News (177660)
Policy (20940)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (2134)
Academic (2)
Accelerated approval (21)
Adcomms (16)
Allergies (95)
Alliances (29003)
ALS (90)
Alzheimer's disease (1122)
Antibody-drug conjugate (ADC) (152)
Approvals (11242)
Artificial intelligence (370)
Autoimmune disease (86)
Automation (20)
Bankruptcy (149)
Best Places to Work (9079)
BIOSECURE Act (8)
Biosimilars (156)
Biotechnology (58)
Bladder cancer (103)
Brain cancer (36)
Breast cancer (362)
Cancer (2584)
Cardiovascular disease (290)
Career advice (516)
Career pathing (15)
CAR-T (119)
CDC (51)
Cell therapy (372)
Cervical cancer (26)
Clinical research (34213)
Collaboration (1078)
Compensation (148)
Complete response letters (22)
COVID-19 (2310)
CRISPR (54)
C-suite (513)
Cystic fibrosis (90)
Data (3786)
Decentralized trials (2)
Denatured (21)
Depression (108)
Diabetes (342)
Diagnostics (5179)
Digital health (46)
Diversity (10)
Diversity, equity & inclusion (24)
Drug discovery (148)
Drug pricing (169)
Drug shortages (12)
Duchenne muscular dystrophy (128)
Earnings (36512)
Editorial (41)
Employer branding (8)
Employer resources (75)
Events (76546)
Executive appointments (667)
FDA (13114)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (5)
Frontotemporal dementia (15)
Funding (1101)
Gene editing (105)
Generative AI (34)
Gene therapy (296)
GLP-1 (601)
Government (4396)
Grass and pollen (6)
Guidances (285)
Healthcare (15138)
HIV (53)
Huntington's disease (18)
IgA nephropathy (49)
Immunology and inflammation (116)
Immuno-oncology (29)
Indications (73)
Infectious disease (2554)
Inflammatory bowel disease (125)
Inflation Reduction Act (16)
Influenza (109)
Intellectual property (117)
Interviews (61)
IPO (7866)
IRA (40)
Job creations (1443)
Job search strategy (456)
JPM (60)
Kidney cancer (5)
Labor market (40)
Layoffs (216)
Leadership (12)
Legal (3956)
Liver cancer (57)
Longevity (12)
Lung cancer (318)
Lymphoma (204)
Machine learning (21)
Management (31)
Manufacturing (411)
MASH (106)
Medical device (9683)
Medtech (9727)
Mergers & acquisitions (11063)
Metabolic disorders (857)
Multiple sclerosis (113)
NASH (10)
Neurodegenerative disease (191)
Neuropsychiatric disorders (62)
Neuroscience (1907)
Neurotech (1)
NextGen: Class of 2026 (5059)
Non-profit (3972)
Now hiring (13)
Obesity (396)
Opinion (163)
Ovarian cancer (81)
Pain (111)
Pancreatic cancer (93)
Parkinson's disease (161)
Partnered (21)
Patents (226)
Patient recruitment (283)
Peanut (32)
People (34024)
Pharmaceutical (31)
Pharmacy benefit managers (29)
Phase 1 (10854)
Phase 2 (13445)
Phase 3 (12144)
Pipeline (3404)
Policy (243)
Postmarket research (1574)
Preclinical (3528)
Press Release (47)
Prostate cancer (145)
Psychedelics (38)
Radiopharmaceuticals (172)
Rare diseases (546)
Real estate (2937)
Recruiting (34)
Regulatory (15664)
Reports (26)
Research institute (1975)
Resumes & cover letters (40)
Rett syndrome (20)
RNA editing (6)
RSV (65)
Schizophrenia (108)
Series A (182)
Series B (139)
Service/supplier (4)
Sickle cell disease (74)
Special edition (11)
Spinal muscular atrophy (95)
Sponsored (28)
Startups (2331)
Stomach cancer (4)
Supply chain (72)
Tariffs (47)
The Weekly (44)
Vaccines (854)
Venture capital (73)
Weight loss (241)
Women's health (84)
Worklife (7)
Date
Today (82)
Last 7 days (387)
Last 30 days (1413)
Last 365 days (18868)
2026 (2058)
2025 (19195)
2024 (21947)
2023 (24466)
2022 (33903)
2021 (37388)
2020 (37823)
2019 (33543)
2018 (25101)
2017 (17915)
2016 (19073)
2015 (21599)
2014 (16188)
2013 (12847)
2012 (13593)
2011 (14061)
2010 (12083)
Location
Africa (536)
Alabama (36)
Alaska (6)
Arizona (187)
Arkansas (12)
Asia (22825)
Australia (4008)
California (6253)
Canada (2199)
China (618)
Colorado (310)
Connecticut (336)
Delaware (194)
Europe (51144)
Florida (993)
Georgia (268)
Hawaii (2)
Idaho (41)
Illinois (605)
India (56)
Indiana (455)
Iowa (13)
Japan (303)
Kansas (89)
Kentucky (27)
Louisiana (24)
Maine (79)
Maryland (957)
Massachusetts (4655)
Michigan (222)
Minnesota (403)
Mississippi (3)
Missouri (121)
Montana (18)
Nebraska (20)
Nevada (93)
New Hampshire (60)
New Jersey (2180)
New Mexico (13)
New York (1966)
North Carolina (975)
North Dakota (4)
Northern California (3124)
Ohio (222)
Oklahoma (13)
Oregon (29)
Pennsylvania (1447)
Puerto Rico (12)
Rhode Island (29)
South America (707)
South Carolina (34)
South Dakota (1)
Southern California (2363)
Tennessee (140)
Texas (965)
United States (24744)
Utah (265)
Virginia (144)
Washington D.C. (53)
Washington State (606)
West Virginia (3)
Wisconsin (90)
Wyoming (2)
416,152 Results for "seed health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ArrayPatch Announces First Close of €3M Seed Round to Advance ITZ-DerMap™ for Treatment of Nail Fungus
February 10, 2026
·
2 min read
Gene editing
Startup Aurora Seeks To Replicate Baby KJ Success With $16M in Seed Money
Aurora joins the clutch of companies linked to Nobel Prize winner and CRISPR trailblazer Jennifer Doudna.
January 12, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Junevity Expands Seed Funding to $20 Million for Cell Reprogramming with siRNA
December 3, 2025
·
3 min read
Press Releases
Amphix Bio raises $12.5M seed round to advance peptide drug platform
December 19, 2025
·
2 min read
Press Releases
BioLumic Expands Light-Activated Seed Trait Platform to South America
December 9, 2025
·
1 min read
Press Releases
Convergen Secures $10 Million Seed Funding to Advance TrimTAC Platform for Neurodegeneration & beyond
December 9, 2025
·
3 min read
Press Releases
SEED Therapeutics Doses First Patient in Phase 1 Trial of ST-01156, a Molecular Glue Degrader Targeting RBM39
January 12, 2026
·
3 min read
Press Releases
Hermes Biosciences Raises Seed Funding to Make Extracellular Vesicles a Practical Tool for Precision Medicine
November 19, 2025
·
3 min read
Press Releases
Optimi Health Completes First 2026 Production of MDMA and Psilocybin Capsules
Australia’s Department of Health has issued import permits for Optimi’s MDMA and psilocybin capsules for use under the Authorised Prescriber Scheme
January 26, 2026
·
1 min read
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
1 of 41,616
Next
